Early Access — free while we kick the tires
EdgarHawk

Scalzo Richard William

SVP, Head of Finance & Admin.

Officer
1 filing analyzed · 1 company · Latest 2024-09-10

Companies

Company Buys Sells Direction
Dyne Therapeutics, Inc. DYN 0 9 Net selling

Activity

September 2024
high
Sell
126,074 shares
$4,052,851
Significance 6/10

SVP Finance of unprofitable DYN sells 126,074 shares (-55.4% of holdings) for $4.05M at $32.15; stock down 25.6% in 30 days

Richard William Scalzo, SVP Head of Finance & Administration, executed 2 separate sales totaling 126,074 shares for $4,052,851.36 at a blended average price of $32.15 on 2024-09-06, reducing his holdings by 55.4% from 227,500 shares to 101,426 shares. The stock has declined 25.6% over the prior 30 days and is trading 31.1% below its 52-week high of $47.04, while the company posted net income of -$65,102,000 in its most recent fiscal year. Scalzo's prior 5 trades at DYN all occurred in March 2024 (well before this September sale) and collectively generated positive 90-day returns ranging from 19.0% to 28.4%, indicating those earlier sales were poorly timed—the stock rose substantially after he sold. This current sale at $32.15 occurs after the stock has already deteriorated significantly, presenting a distinct context from his March pattern of selling into strength.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access